Blog

It has been about a month since the last earnings report for First American Financial (FAF). Shares have lost about 1.5% in that time frame, underperforming the S&P 500.

But investors have to be

A month has gone by since the last earnings report for CACI International (CACI). Shares have lost about 6.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

It has been about a month since the last earnings report for Boston Scientific (BSX). Shares have lost about 13% in that time frame, underperforming the S&P 500.

But investors have to be wondering

It has been about a month since the last earnings report for CME Group (CME). Shares have added about 1.3% in that time frame, underperforming the S&P 500.

Will the recent positive trend continue

It has been about a month since the last earnings report for Boeing (BA). Shares have lost about 6.2% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading

It has been about a month since the last earnings report for Amerisafe (AMSF). Shares have added about 0.7% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will

KLA Corporation’s KLAC service business is steadily evolving into one of its most dependable long-term growth drivers. During the third-quarter fiscal 2026 earnings call, management emphasized that

Flowers Foods, Inc. FLO reported first-quarter fiscal 2026 results, wherein both top and bottom lines beat the Zacks Consensus Estimate. While net sales increased, earnings decreased from the

RF Industries, Ltd.’s RFIL thermal cooling business is emerging as one of its most promising long-term growth drivers. During the first-quarter fiscal 2026 earnings call, management highlighted

The Gap, Inc. GAP is expected to register top-line growth when it reports first-quarter fiscal 2026 results on May 28, after the closing bell. For revenues, the Zacks Consensus Estimate is pegged at

Sales of Merck’s MRK second-largest product, Gardasil, which is a vaccine approved to prevent certain cancers caused by the human papillomavirus, have been declining for some time now. While the

Keros Therapeutics KROS is recasting itself as a neuromuscular execution story, anchored by rinvatercept (KER-065) and a catalyst path that begins in 2026. The shift comes as the company leans into

Keros Therapeutics KROS is recasting itself as a neuromuscular execution story, anchored by rinvatercept (KER-065) and a catalyst path that begins in 2026. The shift comes as the company leans into

Keros Therapeutics KROS posted a messy first-quarter 2026 print, with a wider-than-expected loss and a steep revenue decline. The headline numbers look worse than the underlying operating reality

Keros Therapeutics KROS posted a messy first-quarter 2026 print, with a wider-than-expected loss and a steep revenue decline. The headline numbers look worse than the underlying operating reality

Keros Therapeutics KROS is a clinical-stage biopharmaceutical company developing protein therapeutics that modulate transforming growth factor-beta family signaling across skeletal muscle, bone, and

Keros Therapeutics KROS is a clinical-stage biopharmaceutical company developing protein therapeutics that modulate transforming growth factor-beta family signaling across skeletal muscle, bone, and

Advance Auto Parts, Inc. AAP delivered adjusted earnings of 77 cents per share in the first quarter of 2026, beating the Zacks Consensus Estimate of 39 cents by 95.2%. The company had incurred an

OUTFRONT Media OUT recently launched its inaugural advertising and experiential program at Los Angeles Union Station, creating an in-real-life media environment for brands. The move adds a marquee

We look to open the final trading day for the week higher, after a Thursday session in the green that brought the blue-chip Dow to all-time closing highs. Promises of an end to the war in Iran joins

3M Company MMM has been plagued by softness in its Consumer segment of late. In the first quarter of 2026, the company’s Consumer segment’s adjusted organic revenues declined 1.3% year over year

Copart, Inc. CPRT delivered third-quarter fiscal 2026 earnings of 43 cents per share, which rose 2.4% year over year and beat the Zacks Consensus Estimate of 41 cents by 4.9%. Quarterly revenues

Hormel Foods Corporation HRL is likely to witness top-line growth when it reports second-quarter fiscal 2026 earnings on May 28. The Zacks Consensus Estimate for revenues is pegged at $2.94 billion

Deckers Outdoor Corporation DECK reported fourth-quarter fiscal 2026 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate. DECK reported earnings of 96 cents per share

Digital advertising remains one of the most attractive long-term growth markets in the technology space. According to a Precedence Research report, the global digital advertising market is expected